BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15520071)

  • 21. Durable complete remission with combination chemotherapy and bortezomib in HIV-associated plasmablastic lymphoma.
    Arora N; Gupta A; Sadeghi N
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28993364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
    Ruan J; Moskowitz A; Mehta-Shah N; Sokol L; Chen Z; Kotlov N; Nos G; Sorokina M; Maksimov V; Sboner A; Sigouros M; van Besien K; Horwitz S; Rutherford SC; Mulvey E; Revuelta MV; Xiang J; Alonso A; Melnick A; Elemento O; Inghirami G; Leonard JP; Cerchietti L; Martin P
    Blood; 2023 May; 141(18):2194-2205. PubMed ID: 36796016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
    Stuver R; Horwitz SM; Advani RH; Vose JM; Lee HJ; Mehta-Shah N; Zain JM; Haverkos B; Lechowicz MJ; Moskowitz AJ; Pham LQ; Leyden E; Ansell SM; Lunning MA
    Br J Haematol; 2023 Aug; 202(3):525-529. PubMed ID: 37217196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress in dogs with multicentric lymphoma: Effect of chemotherapy on oxidative and antioxidant biomarkers.
    Bottari NB; Munhoz TD; Torbitz VD; Tonin AA; Anai LA; Semolin LM; Jark PC; Bollick YS; Moresco RN; França RT; Lopes ST; Stefani LM; Tinucci-Costa M; Da Silva AS
    Redox Rep; 2015; 20(6):267-74. PubMed ID: 26274787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal T-cell lymphomas NOS presenting as a polypoidal lesion: A case report.
    Bi H; Bai J; Wang L; Liang C; Wu Y
    Medicine (Baltimore); 2024 Jun; 103(23):e38465. PubMed ID: 38847694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study.
    Zhang W; Su L; Liu L; Gao Y; Wang Q; Su H; Song Y; Zhang H; Shen J; Jing H; Wang S; Cen X; Liu H; Liu A; Li Z; Luo J; He J; Wang J; O'Connor OA; Zhou D
    Cancer Biol Med; 2021 Mar; 18(3):841-8. PubMed ID: 33755379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report: Successful treatment of Chidamide in a refractory/recurrent SPTCL with ARID1A mutation on the basis of CHOP plus auto-HSCT.
    Zhang N; Zhang S; Ma L; Qiu L; Meng QL; Cai J; Xu Z; Yao H; Fan FY
    Medicine (Baltimore); 2023 Oct; 102(40):e35413. PubMed ID: 37800816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.
    Barr PM; Lazarus HM; Cooper BW; Schluchter MD; Panneerselvam A; Jacobberger JW; Hsu JW; Janakiraman N; Simic A; Dowlati A; Remick SC
    Am J Hematol; 2009 Aug; 84(8):484-7. PubMed ID: 19536846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.
    Ratner L; Harrington W; Feng X; Grant C; Jacobson S; Noy A; Sparano J; Lee J; Ambinder R; Campbell N; Lairmore M;
    PLoS One; 2009; 4(2):e4420. PubMed ID: 19204798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase 2 study of pegylated liposomal doxorubicin plus cyclophosphamide, vincristine/vindesine, and prednisone in newly diagnosed PTCL: 8-year results.
    Xia ZG; Lv FF; Zhang QL; Liu YZ; Zhang SJ; Liu C; Li XQ; Wen Y; Wu ZY; Hong XN; Guo Y; Cao JN
    Oncologist; 2024 May; ():. PubMed ID: 38821519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics, genetic alterations, and prognosis of adult T-cell leukemia/lymphoma: an 11-year multicenter retrospective study in China.
    Luo L; Chen Y; Wu Z; Huang Y; Lu L; Li J; Zheng X; Nie C; Chen R; Lin W; Yang T; Hu J
    Am J Cancer Res; 2024; 14(4):1649-1661. PubMed ID: 38726267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unraveling the mystery of fever of unknown origin: a remarkable journey towards the diagnosis of peripheral T-cell lymphoma-T follicular helper type: A rare case report.
    Trifonov PI; Koltchakov VK; Mihaylova-Garnizova RP; Yordanov AY; Sokolova L; Nikolov RK; Krastev ZA
    Medicine (Baltimore); 2024 Jan; 103(3):e36974. PubMed ID: 38241538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma.
    Boyé P; Serres F; Marescaux L; Hordeaux J; Bouchaert E; Gomes B; Tierny D
    PLoS One; 2017; 12(5):e0177486. PubMed ID: 28505195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intradermal administration of lipopolysaccharide in treatment of human cancer.
    Goto S; Sakai S; Kera J; Suma Y; Soma GI; Takeuchi S
    Cancer Immunol Immunother; 1996 May; 42(4):255-61. PubMed ID: 8665574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.
    Stuver R; Epstein-Peterson ZD; Horwitz SM
    Haematologica; 2023 Dec; 108(12):3244-3260. PubMed ID: 38037801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Histopathological Features of an Italian Monocentric Series of Primary Small Bowel T-Cell Lymphomas.
    Lucioni M; Fraticelli S; Santacroce G; Bonometti A; Aronico N; Sciarra R; Lenti MV; Bianchi PI; Neri G; Feltri M; Neri B; Ferrario G; Riboni R; Corazza GR; Vanoli A; Arcaini L; Paulli M; Di Sabatino A
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Risk of Malignancies in Celiac Disease-A Literature Review.
    Pelizzaro F; Marsilio I; Fassan M; Piazza F; Barberio B; D'Odorico A; Savarino EV; Farinati F; Zingone F
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy.
    Voorhees TJ; Ghosh N; Grover N; Block J; Cheng C; Morrison K; Ivanova A; Dotti G; Serody J; Savoldo B; Beaven AW
    Blood Adv; 2020 Dec; 4(23):5925-5928. PubMed ID: 33259598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment outcomes of IMEP as a front-line chemotherapy for patients with peripheral T-cell lymphomas.
    Lee JY; Lee SM; Choi MY; Kim KH; Joo YD; Im SN; Lee WS
    Blood Res; 2016 Sep; 51(3):187-192. PubMed ID: 27722130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.
    Fend F; Cabecadas J; Gaulard P; Jaffe ES; Kluin P; Kuzu I; Peterson L; Wotherspoon A; Sundström C
    J Hematop; 2012 Sep; 5(3):. PubMed ID: 24307917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.